Document is current
Any future updates will be listed below
-
Authors
Amelunxen, Eric
Kokot, Amelie
Kolbrink, Benedikt
Thomsen, Sarah-Yasmin
Meßtorff, Maja L.
Laudes, Matthias
Lienhard, Kenny R.
Bachmann, Lucas M.
Sievers, Laura K.
Schmitt, Roland
Schulte, Kevin
von Samson-Himmelstjerna, Friedrich A.
-
Funding
Funding for this research was provided by:
Universitätsklinikum Schleswig-Holstein - Campus Kiel
- License Information
-
More Information
Article History
Received: 5 March 2026
Accepted: 26 May 2026
First Online: 5 June 2026
Declarations
:
: This study was approved by the Ethics Committee of the Christian-Albrechts-University of Kiel under the sign AZ D616/25. The study is conducted according to the Declaration of Helsinki.
: Not applicable.
: S.Y.T. reports honoraria from AstraZeneca GmbH and travel support from Lilly GmbH. M.L. and K.S. report honoraria from Lilly GmbH, Boehringer Ingelheim International GmbH, AstraZeneca GmbH and Novo Nordisk Pharma GmbH. L.K.S. received honoraria and travel support from Boehringer Ingelheim, Lilly GmbH and AstraZeneca GmbH. R.S. reports honoraria from Lilly GmbH and AstraZeneca GmbH. F.A.v.S.-H. reports honoraria and travel support from Lilly GmbH and AstraZeneca GmbH. F.A.v.S.-H. and B.K. are supported by the Medical Faculty of the Christian-Albrechts-University Kiel. The other authors declare no conflicts of interest.
